Quizartinib, sold under the brand name Vanflyta, is an anti-cancer medication used for the treatment of acute myeloid leukemia. [2] It is a small molecule receptor tyrosine kinase …

2023年11月28日 · Quizartinib is used in adults alone or in combination with other cancer treatments to treat acute myeloid leukemia. Quizartinib is available only from a certified …

2023年8月8日 · Quizartinib is an anticancer (antineoplastic) medication used to treat newly diagnosed acute myeloid leukemia (AML) that is positive for a specific gene mutation known …

Quizartinib is used in combination with other medicines (eg, cytarabine, anthracycline) and alone as maintenance therapy to treat acute myeloid leukemia in patients with a FLT3-ITD mutation. …

Quizartinib is used with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML; a type of cancer of the white blood cells). Quizartinib is in a class of …

VANFLYTA is a prescription medicine used in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults with newly diagnosed acute myeloid …

Quizartinib dihydrochloride is approved to treat: Acute myeloid leukemia that is newly diagnosed and has a certain mutation in the FLT3 gene. It is used in adults, first with cytarabine and an …

2024年11月10日 · Used in combination with standard cytarabine and anthracycline induction and cytarabine consolidation therapies, and as maintenance monotherapy following consolidation …

2023年7月26日 · Quizartinib is a prescription medication used in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance …

Quizartinib is indicated in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation …